» Articles » PMID: 28122968

Phosphoprotein Profiles of Candidate Markers for Early Cellular Responses to Low-dose γ-radiation in Normal Human Fibroblast Cells

Overview
Journal J Radiat Res
Date 2017 Jan 27
PMID 28122968
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Ionizing radiation causes biological damage that leads to severe health effects. However, the effects and subsequent health implications caused by exposure to low-dose radiation are unclear. The objective of this study was to determine phosphoprotein profiles in normal human fibroblast cell lines in response to low-dose and high-dose γ-radiation. We examined the cellular response in MRC-5 cells 0.5 h after exposure to 0.05 or 2 Gy. Using 1318 antibodies by antibody array, we observed ≥1.3-fold increases in a number of identified phosphoproteins in cells subjected to low-dose (0.05 Gy) and high-dose (2 Gy) radiation, suggesting that both radiation levels stimulate distinct signaling pathways. Low-dose radiation induced nucleic acid-binding transcription factor activity, developmental processes, and multicellular organismal processes. By contrast, high-dose radiation stimulated apoptotic processes, cell adhesion and regulation, and cellular organization and biogenesis. We found that phospho-BTK (Tyr550) and phospho-Gab2 (Tyr643) protein levels at 0.5 h after treatment were higher in cells subjected to low-dose radiation than in cells treated with high-dose radiation. We also determined that the phosphorylation of BTK and Gab2 in response to ionizing radiation was regulated in a dose-dependent manner in MRC-5 and NHDF cells. Our study provides new insights into the biological responses to low-dose γ-radiation and identifies potential candidate markers for monitoring exposure to low-dose ionizing radiation.

Citing Articles

Comparison of the Medical Uses and Cellular Effects of High and Low Linear Energy Transfer Radiation.

Russ E, Davis C, Slaven J, Bradfield D, Selwyn R, Day R Toxics. 2022; 10(10).

PMID: 36287908 PMC: 9609561. DOI: 10.3390/toxics10100628.


The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation.

Heo S, Noh E, Lee Y, Shin Y, Kim Y, Im H BMC Cancer. 2022; 22(1):997.

PMID: 36127634 PMC: 9487033. DOI: 10.1186/s12885-022-10096-3.


Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: A Systematic Review.

Subedi P, Gomolka M, Moertl S, Dietz A J Pers Med. 2021; 11(2).

PMID: 33669522 PMC: 7922485. DOI: 10.3390/jpm11020140.


Biological effects of low-dose γ-ray irradiation on chromosomes and DNA of Drosophila melanogaster.

Tanaka Y, Furuta M J Radiat Res. 2020; 62(1):1-11.

PMID: 33290547 PMC: 7779362. DOI: 10.1093/jrr/rraa108.


Analysis of a lectin microarray identifies altered sialylation of mouse serum glycoproteins induced by whole-body radiation exposure.

Iizuka D, Izumi S, Suzuki F, Kamiya K J Radiat Res. 2018; 60(2):189-196.

PMID: 30521038 PMC: 6430252. DOI: 10.1093/jrr/rry100.

References
1.
Wada T, Nakashima T, Oliveira-dos-Santos A, Gasser J, Hara H, Schett G . The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. Nat Med. 2005; 11(4):394-9. DOI: 10.1038/nm1203. View

2.
Kastan M, Zhan Q, El-Deiry W, Carrier F, Jacks T, Walsh W . A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 1992; 71(4):587-97. DOI: 10.1016/0092-8674(92)90593-2. View

3.
van Attikum H, Gasser S . Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol. 2009; 19(5):207-17. DOI: 10.1016/j.tcb.2009.03.001. View

4.
Uckun F, Waddick K, Mahajan S, Jun X, Takata M, Bolen J . BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science. 1996; 273(5278):1096-100. DOI: 10.1126/science.273.5278.1096. View

5.
Smith-Bindman R, Lipson J, Marcus R, Kim K, Mahesh M, Gould R . Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009; 169(22):2078-86. PMC: 4635397. DOI: 10.1001/archinternmed.2009.427. View